...
首页> 外文期刊>Agricultural Economics Research Review >Potential Role of Technology in Increasing Productivity and Income at National Level: A Case of Cell-culture Vaccine against Classical Swine Fever
【24h】

Potential Role of Technology in Increasing Productivity and Income at National Level: A Case of Cell-culture Vaccine against Classical Swine Fever

机译:技术在国家一级生产力和收入增加的潜在作用:一种针对古典猪瘟的细胞培养疫苗的情况

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Classical swine fever (CSF) is one of the important diseases of pigs causing high mortality. The ICAR-Indian Veterinary Research Institute, Izatnagar, has developed a cell culture vaccine for this disease during the period 2002-2008. The vaccine willmost probably be marketed by various agencies, in both public and private sectors by 2017-18. The present study attempts to evaluate the potential economic feasibility of CSF control programme using the above vaccine at the national level using economicsurplus model. The potential change in total surplus, as a result of CSF control programme is found to be 53.31 crore per annum. The change in economic surplus and the research & delivery costs was projected to 2030. Using a long-run discount rate of 7.5 per cent, the benefits were compared to research & delivery cost and the NPV, IRR and BCR were calculated. The NPV, IRR and BCR of CSF control programme are found to be 322.55 crore, 40 per cent and 41:1, respectively. Sensitivity analysis has revealed that the benefits are most sensitive to assumptions regarding lower degree of immunity offered by the vaccine and a higher discount rate. The changes in results of the model, based on baseline assumption, were negligible for changes in assumption in regard to adoption rates, ceiling level of adoption and higher demand elasticity.
机译:古典猪瘟(CSF)是猪的重要疾病之一,导致高死亡率。 ICAR-印度兽医研究院Izatnagar在2002 - 2008年期间开发了这种疾病的细胞培养疫苗。到2017 - 18年,在公共和私营部门,疫苗最大可能由各种机构销售。本研究试图利用经济学模型在国家一级使用上述疫苗来评估CSF控制程序的潜在经济可行性。由于CSF控制程序,总盈余的潜在变化被发现为每年53.31卢比。经济盈余的变化和研究和交付成本预计为2030年。使用7.5%的长期折扣率,与研究和交付成本和NPV,IRR和BCR进行了比较。 CSF控制程序的NPV,IRR和BCR分别为322.55亿卢比,40%和41:1。敏感性分析表明,对疫苗提供的较低免疫程度和更高的折扣率的假设最敏感。基于基线假设的模型结果的变化对于采用率,天花板采用和更高的需求弹性的假设变化可以忽略不计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号